540204 EIKO

Eiko Lifesciences Share Price

 

 

Start SIP in EIKO

Start SIP

Performance

  • Low
  • ₹50
  • High
  • ₹52
  • 52 Week Low
  • ₹42
  • 52 Week High
  • ₹66
  • Open Price₹50
  • Previous Close₹53
  • Volume13,370
  • 50 DMA₹52.42
  • 100 DMA₹52.72
  • 200 DMA₹53.30

Investment Returns

  • Over 1 Month -3.12%
  • Over 3 Month -9.91%
  • Over 6 Month -5.23%
  • Over 1 Year -8.11%

Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!

Invest Now

Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 71
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.4
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.25
  • RSI
  • 46.29
  • MFI
  • 45.96

Eiko Lifesciences Financials

Eiko Lifesciences Technicals

EMA & SMA

Current Price
₹51.79
-1.63 (-3.05%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹52.08
  • 50 Day
  • ₹52.42
  • 100 Day
  • ₹52.72
  • 200 Day
  • ₹53.30

Resistance and Support

51.08 Pivot Speed
  • R3 53.89
  • R2 52.94
  • R1 52.03
  • S1 50.17
  • S2 49.22
  • S3 48.31

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Eiko Lifesciences has an operating revenue of Rs. 45.64 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 8% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 2% and 1% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 93 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of E is the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-29 Quarterly Results
2025-12-11 Others Inter alia, To consider the proposal for raising of funds by way of issue of one or more of instruments comprising of Equity Shares, Convertible Securities through Private Placement/Preferential Issue 1) Matter relating to payment of First and final call money on 55,44,178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02, 2023.
2025-10-31 Quarterly Results
2025-07-29 Quarterly Results
2025-05-14 Audited Results

Eiko Lifesciences F&O

Eiko Lifesciences Shareholding Pattern

37.17%
43.37%
19.46%

Eiko Lifesciences FAQs

Eiko Lifesciences share price is ₹51 As on 07 February, 2026 | 08:30

The Market Cap of Eiko Lifesciences is ₹71.1 Cr As on 07 February, 2026 | 08:30

The P/E ratio of Eiko Lifesciences is 16.8 As on 07 February, 2026 | 08:30

The PB ratio of Eiko Lifesciences is 1.2 As on 07 February, 2026 | 08:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23